Nasdaq · CIK 0001716947
ENSC Ensysce Biosciences, Inc.
Insider trading from SEC Form 4. Last filing Aug 18, 2026. Close $0.57 on Oct 13, 2026, +128% from the 52-week low and -78% from the high.
In brief
Ensysce Biosciences, Inc. (ENSC) has 4 SEC Form 4 filings on file from 1 insider, the latest filed on Aug 18, 2026. In the last 90 days insiders made 1 open-market buy worth $444k and 0 open-market sells worth $0, net +$444k.
4 open-market trades have been scored at ENSC. The newest: Bob G Gower (director) bought $444k of stock on Apr 23, 2026, filed Aug 18, 2026, scored 42 (moderate). The largest of the 4 shown: Bob G Gower (director) bought $500k on Dec 9, 2022, scored 51 (moderate).
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Ensysce Biosciences, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 42Moderate | Bob G Gower director buy | $444k 908,614 shares | first purchase | - | |
| 37Weak | Bob G Gower director buy | $44k 90,287 shares | +8% | +10% from low-98% from high | |
| 60Notable | Bob G Gower director buy | $182k 379,300 shares | +50% | +2% from low-98% from high | |
| 51Moderate | Bob G Gower director buy | $500k 357,143 shares | +90% | +21% from low-99% from high |
Transactions
Every row filed, 8 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | Bob G Gower director | POpen-market purchase Common Stock | +508,614 | $0.48 | $246k | 516,740 | Aug 18, 2026 |
| Aug 7, 2026 | Bob G Gower director | POpen-market purchase Common Stock | +400,000 | $0.50 | $198k | 916,740 | Aug 18, 2026 |
| Apr 23, 2026 | Bob G Gower director | CConversion Warrantderivative | +254,307 | - | - | 289,836 | Aug 18, 2026 |
| Mar 2, 2023 | Bob G Gower director | POpen-market purchase Common Stock | +90,287 | $0.49 | $44k | 1,222,682 | Mar 6, 2023 |
| Feb 28, 2023 | Bob G Gower director | POpen-market purchase Common Stock | +109,300 | $0.49 | $53k | 862,395 | Mar 2, 2023 |
| Mar 1, 2023 | Bob G Gower director | POpen-market purchase Common Stock | +270,000 | $0.48 | $129k | 1,132,395 | Mar 2, 2023 |
| Dec 9, 2022 | Bob G Gower director | POpen-market purchase Common Stock | +357,143 | $1.40 | $500k | 753,095 | Feb 1, 2023 |
| Dec 9, 2022 | Bob G Gower director | AGrant or award Warrantsderivative | +714,286 | - | - | 716,365 | Feb 1, 2023 |
Questions about ENSC
Answered from the filings on this page, as of the latest one.
Are insiders buying ENSC?
As of Aug 18, 2026, SEC Form 4 filings show 1 open-market buy worth $444k by 1 insider and 0 open-market sells worth $0 by 0 insiders at Ensysce Biosciences, Inc. in the last 90 days, net +$444k. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.
Who was the last insider to trade ENSC on the open market?
Bob G Gower (director) bought $444k of ENSC on Apr 23, 2026 and filed the Form 4 on Aug 18, 2026. InsiderTell scored 42 (moderate).
How many insiders file Form 4 at Ensysce Biosciences, Inc.?
1 person has filed a Form 4 at Ensysce Biosciences, Inc., among them Bob G Gower (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.